昊海生物科技(06826.HK)拟对软性隐形眼镜业务进行投资
格隆汇 4 月 8日丨昊海生物科技(06826.HK)公告,上海昊海生物科技股份有限公司(“公司”或“昊海生科”)下属全资子公司上海昊海医药科技发展有限公司(“昊海发展”)与河北鑫视康隐形眼镜有限公司(“河北鑫视康”或“目标公司”)及河北鑫达盒业有限公司、李景强、徐存敬(合称“原股东”)签署《增资协议》,约定昊海发展以人民币4000万元现金认购目标公司新增注册资本人民币4000万元,本次增资完成后,昊海发展将获得目标公司60%的股权(“本次交易”)。本次交易完成后,河北鑫视康将成为昊海发展的控股子公司,纳入公司合并报表。
目标公司主要从事具有近视矫正功能的软性亲水接触镜(以下简称“软性隐形眼镜”)产品的研发、生产及销售,截至目前已取得国家药品监督管理局批准的4项软性隐形眼镜产品的医疗器械注册证,包括日抛型及年抛型透明软性隐形眼镜,以及日抛型及年抛型彩色软性隐形眼镜。
本次交易完成后,一方面昊海生科视光产品线补充了兼具近视矫正及消费美妆属性的软性隐形眼镜产品。另一方面,公司可利用积累的视光材料研发能力及周边离焦近视防控等技术,借助目标公司成熟的软性隐形眼镜生产工艺及规模化产能,将公司在研的带有近视控制功能的软性角膜接触镜(“软性近视控制镜”)等相关产品于目标公司落地实施,加快公司该类产品的研发进程,进一步充实视光产品线。
鉴于公司目前视光产品线未复盖软性隐形眼镜业务,本次交易完成后相关业务是否可以达到预期整合目的尚具有不确定性;同时,目标公司产品未形成规模化销售,业务是否持续增长亦具有不确定性;此外,公司软性近视控制镜产品尚处于临床前开发阶段,本次交易后相关产品的后续开发及获批上市存在一定风险。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.